Introduction {#sec1}
============

Carbohydrates are recognized as environmentally friendly starting materials with several key characteristics, including abundant availability, high water solubility, and optical activity.^[@ref1]^ Synthesis of biologically active compounds, design of molecular recognition devices, and their use as chiral auxiliaries in asymmetric synthesis are discussed in most of the utilization reports on carbohydrates.^[@ref2]−[@ref4]^ The existence of a large number of free hydroxyl groups in the structure of carbohydrates caused their high solubility in an aqueous environment. Thus, the water solubility of a biologically active molecule can be tuned by incorporation of a carbohydrate moiety in its structure. Due to these facts, there are a lot of applications for carbohydrate derivatives in medicinal chemistry. Several drugs based on carbohydrates for antibiotics, antiviral, protein glycosylation, and glycosylation inhibitors have been developed.^[@ref5]−[@ref8]^

Moreover, carbohydrates have been used as reagent in organic synthesis to obtain new organic molecules containing carbohydrate fragments. Along this line, some of the heterocycles, including pyrazines, imidazoles, quinoxalines, pyrazolo\[3,4-*b*\]-quinoxalines, and benzimidazoles, have been synthesized using carbohydrates as reagent.^[@ref9]−[@ref15]^ For example, there are some reports on the use of carbohydrate-based heterocycles as corrosion inhibitor of mild steels.^[@ref16],[@ref17]^

One of the most important strategies to provide structurally diverse natural productlike compounds is multicomponent reaction (MCR).^[@ref18]−[@ref20]^ MCR is a smart synthetic strategy, because it is possible to make a complex product in a single step, whereas molecular diversity can be simply achieved by the selection of desired components. In this situation, MCRs are widely used to generate new compounds based on carbohydrate derivatives. According to the functionality of carbohydrate, it is possible to consider it as a component in MCRs. For example, reducing sugars can be used as aldehyde and amino sugars as amine component. The presence of a carbohydrate as aldehyde or an amine component in MCRs opens our hands in the synthesis of new carbohydrate-based library molecules.^[@ref21]−[@ref25]^

Aminocarbonitrile derivatives are an important class of organic molecules that possess many applications in organic synthesis. In this regard, preparation of aminocarbonitriles is very attractive and MCRs are useful approaches in the synthesis of aminocarbonitrile derivatives.^[@ref26]−[@ref31]^ More importantly, aminocarbonitriles also showed interesting biological activities. For instance, there is a report on anticancer activity of some 2-amino-chromene-nitriles.^[@ref32]^

Oxidative stress causes an imbalance between creation and accumulation of oxygen reactive species in cells and tissue, playing a major role in the progress of various chronic and degenerative illnesses, such as aging, cancer, cataract, autoimmune disorders, rheumatoid arthritis, cardiovascular, and neurodegenerative diseases. The human body has several mechanisms to offset oxidative stress by producing antioxidants, which are either naturally produced in human body or externally provided through foods and/or supplements.^[@ref33]^ However, without exogenous antioxidant compounds, our endogenous antioxidant defense systems are incomplete. Hence, there are continuous requests for exogenous antioxidants to prevent oxidative stress.^[@ref34]^

Previously, our research group reported on the use of natural small molecules, including carbohydrates, nucleosides, and curcumin, in MCRs for one-pot synthesis of some biologically active compounds.^[@ref35]−[@ref41]^ In continuation of our program on the synthesis of natural product-based compound libraries, in this study, we disclosed a new MCR between carbohydrates, β-dicarbonyl compounds, and malononitrile. This combinatorial reaction afforded synthesis of novel classes of pyrano\[2,3-*d*\]pyrimidine, pyrido\[2,3-*d*\]pyrimidine, and chromene derivatives, incorporating carbohydrate moieties. Also, the antioxidant activity of the synthetic compounds was investigated, demonstrating that all of them have reasonable antioxidant activity.

Results and Discussion {#sec2}
======================

Initially, (+)-[d]{.smallcaps}-glucose (**1a**) was reacted with barbituric acid (**2a**) and malononitrile (**3a**) in EtOH in the presence of 20 mol % *para*-toluenesulfonic acid (PTSA) to give glucose analogue **4a** as a white crystal in 85% isolated yield ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![One-Pot Synthesis of a Pyrano\[2,3-*d*\]pyrimidine-6-carbonitrile Based on (+)-[d]{.smallcaps}-Glucose\
Reaction conditions: (+)-[d]{.smallcaps}-glucose (1 mmol), barbituric acid (1 mmol), malononitrile (1 mmol), EtOH (5 mL), and PTSA (20 mol %).](ao-2018-01124q_0008){#sch1}

To find the optimum condition for this reaction, different experiments were done on the above reaction ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}) and results are shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}.

###### Optimization of Reaction Condition[a](#t1fn1){ref-type="table-fn"}

  entry   catalyst (mol %)               solvent   temp (°C)   time (h)   yield **4a** (%)[b](#t1fn2){ref-type="table-fn"}
  ------- ------------------------------ --------- ----------- ---------- --------------------------------------------------
  1       none                           EtOH      50          24         15
  2       PTSA (20)                      EtOH      50          12         85
  3       PTSA (30)                      EtOH      50          12         89
  4       PTSA (35)                      EtOH      50          12         88
  5       [l]{.smallcaps}-proline (10)   EtOH      50          18         68
  6       Et~3~N (50)                    EtOH      50          24         52
  7       PTSA (30)                      H~2~O     80          24         65
  8       PTSA (30)                      CH~3~CN   70          24         25
  9       PTSA (30)                      EtOH      35          24         65
  10      PTSA (30)                      EtOH      rt          24         35
  11      PTSA (30)                      EtOH      80          12         90

Reaction conditions: (+)-[d]{.smallcaps}-glucose (1 mmol), barbituric acid (1 mmol), malononitrile (1 mmol), EtOH (5 mL), and catalyst.

Isolated yield.

As shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, low yield of product was obtained in the absence of catalyst in reflux ethanol condition after 24 h ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). The reaction yield was enhanced to 85% after addition of 20 mol % PTSA as catalyst ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2). An improvement in yield was observed by use of 30 mol % of catalyst ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). There was no improvement in the reaction yield with increasing the amount of catalyst to 35 mol % ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). Thus 30 mol % of PTSA as catalyst was recognized as optimum catalyst loading for the reaction. For comparison, two other catalysts, including [l]{.smallcaps}-proline and Et~3~N, were also tested but no improvement in reaction yield was detected ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 5 and 6). Other solvents including water and acetonitrile were also checked, and no superiority in reaction yield was observed ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 7 and 8). Decreasing the reaction temperature reduces the reaction yield significantly so that at room temperature, only 35% of the product was isolated ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 9 and 10). Also, no improvement in the reaction yield was observed by increase of the reaction temperature to 80 °C ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11).

After optimization study, to show the generality and scope of the protocol, some new derivatives using different sugars were synthesized and results are summarized in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}.

![One-Pot Synthesis of a Pyrano\[2,3-*d*\]pyrimidine Derivatives Using MCR of Sugars, Barbituric Acid, and Malononitrile\
Reaction conditions: sugar (1 mmol), barbituric acid (1 mmol), malononitrile/diethyl malonate/ethyl 2-cyanoacetate (1 mmol), EtOH (5 mL), and PTSA (30 mol %).](ao-2018-01124q_0005){#sch2}

As shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, this methodology is efficient for the synthesis of diverse pyrano\[2,3-*d*\]pyrimidine derivatives using different sugars and malononitrile/diethyl malonate/ethyl 2-cyanoacetate. Since only the anomeric carbon engaged in the reaction, it is logical that the enantiomeric centers remain unchanged in the product.

By the use of galactose instead of glucose in the reaction, compound **4b** was obtained in 88% isolated yield. Arabinose as a pentose was also used in the reaction and afforded compound **4c**, incorporating a 4-hydroxy carbon chain. Lactose and maltose were also used as disaccharide carbohydrate to show further applicability of this method in the synthesis of other polyhydroxy-substituted pyrano\[2,3-*d*\]pyrimidines (**4d** and **4e**).

With this procedure, diethyl malonate was also obtained and ester derivative of polyhydroxy-substituted pyrano\[2,3-*d*\]pyrimidine was synthesized in good to excellent yields (**4f**--**i**). As shown, both monosaccharides and disaccharides underwent the reaction to afford corresponding products under optimized conditions.

Ethyl 2-cyanoacetate is another reagent that was used in this protocol, and β-amino ester derivatives of pyrano\[2,3-*d*\]pyrimidines were obtained (**4j** and **4k**).

In another attempt, cyclohexane-1,3-dione was used instead of barbituric acid and this reaction resulted to polyhydroxy-functionalized chromene-3-carbonitrile derivatives ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). These experiments resulted in the production of compounds **6a** and **6b** in 78 and 84% under optimized conditions, respectively. Compound **6a** was obtained from glucose and **6b** was obtained from lactose.

![One-Pot Synthesis of Chromene-3-carbonitrile Derivatives Using MCR of Sugars, Cyclohexane-1,3-dione, and Malononitrile\
Reaction conditions: sugar (1 mmol), cyclohexane-1,3-dione (1 mmol), malononitrile (1 mmol), EtOH (5 mL), and PTSA (30 mol %).](ao-2018-01124q_0001){#sch3}

To show the generality and scope of the reaction further, a four-component coupling reaction was conducted between [d]{.smallcaps}-glucosamine, aldehyde, barbituric acid, and malononitrile. This MCR resulted in the generation of pyrido\[2,3-*d*\]pyrimidine derivatives in good to excellent yields ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). In this reaction, it is possible to synthesize different derivatives using a selection of different aldehydes. Both electron-donating and electron-withdrawing aldehydes gave products under standard conditions. For aldehydes with electron-withdrawing group such as nitro and cyano, more than 92% of product was isolated (**8a** and **8d**). As shown in this reaction, [d]{.smallcaps}-glucosamine (an amino sugar) acts as an amine component.

![One-Pot Synthesis of a Class of Pyrido\[2,3-*d*\]pyrimidine Derivatives Using a Four-Component Reaction of [d]{.smallcaps}-Glucosamine, Aldehyde, Barbituric Acid, and Malononitrile\
Reaction conditions: [d]{.smallcaps}-glucosamine (1 mmol), barbituric acid (1 mmol), malononitrile (1 mmol), aldehyde (1 mmol), EtOH (5 mL), and PTSA (10 mol %). All yields refer to isolated products.](ao-2018-01124q_0002){#sch4}

In view of the reaction mechanism ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}), according to the literature,^[@ref42],[@ref43]^ it seems that the first activated dicarbonyl compound reacts with sugar as an aldehyde component to form a Knoevenagel intermediate (**A**). Reaction of malononitrile to the Knoevenagel intermediate resulted in the production of (**B**). Nucleophilic addition of hydroxy group in enol form with cyano group resulted in the formation of intermediate (**C**). The tautomerization in this intermediate affords pyrano\[2,3-*d*\]pyrimidine and chromene derivatives.

![Proposed Mechanism for Polyhydroxy-Functionalized Pyrano\[2,3-*d*\]pyrimidine and Chromene Derivatives](ao-2018-01124q_0004){#sch5}

In the four-component reaction ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}),^[@ref42],[@ref43]^ the reaction proceeds with the formation of Knoevenagel intermediate between barbituric acid and aldehyde (**D**). Michael addition of malononitrile with the Knoevenagel intermediate led to the production of an intermediate (**E**). It is proposed that in this stage, [d]{.smallcaps}-glucosamine as an amine component reacts with the intermediate (**E**) and forms enamine (**F**), which is highly disposed to undergo cyclization via reaction of amino group and cyano group.

![Proposed Reaction Mechanism for One-Pot Synthesis of Pyrido\[2,3-*d*\]pyrimidine Derivatives Using [d]{.smallcaps}-Glucose Amine](ao-2018-01124q_0006){#sch6}

After synthesis and characterization of the carbohydrate derivatives, their antioxidant activity was evaluated and results were expressed as Trolox equivalent antioxidant capacity (TEAC). The higher TEAC value shows the higher antioxidant power of the compound, as shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The results indicated that all of these synthetic compounds have significant antioxidant activity, and among them, compound **4j** with the TEAC value of 5.237 ± 0.053 μM displays the most antioxidant activity than other synthetic compounds. Also, thereafter, **4k** and **4c**, respectively, stand in the second and third positions on the basis of their antioxidant activity.

###### Comparison between Antioxidant Activities (As TEAC) of Different Synthesized Compounds at Specific Time Points

  synthetic compounds   carbohydrate part             heterocycle fragments          TEAC ± SD (μM)
  --------------------- ----------------------------- ------------------------------ ----------------
  **4a**                glucose                       pyrano\[2,3-*d*\]pyrimidines   3.208 ± 0.053
  aminocarbonitrile                                                                  
  **4b**                galactose                     pyrano\[2,3-*d*\]pyrimidines   1.234 ± 0.014
  aminocarbonitrile                                                                  
  **4c**                arabinose                     pyrano\[2,3-*d*\]pyrimidines   4.914 ± 0.196
  aminocarbonitrile                                                                  
  **4d**                lactose                       pyrano\[2,3-*d*\]pyrimidines   3.909 ± 0.008
  aminocarbonitrile                                                                  
  **4e**                maltose                       pyrano\[2,3-*d*\]pyrimidines   3.070 ± 0.070
  aminocarbonitrile                                                                  
  **4f**                glucose                       pyrano\[2,3-*d*\]pyrimidine    3.959 ± 0.029
  β-keto ester                                                                       
  **4g**                galactose                     pyrano\[2,3-*d*\]pyrimidine    3.744 ± 0.025
  β-keto ester                                                                       
  **4h**                lactose                       pyrano\[2,3-*d*\]pyrimidine    3.995 ± 0.036
  β-keto ester                                                                       
  **4i**                maltose                       pyrano\[2,3-*d*\]pyrimidine    2.216 ± 0.019
  β-keto ester                                                                       
  **4j**                maltose                       pyrano\[2,3-*d*\]pyrimidine    5.237 ± 0.053
  β-amino ester                                                                      
  **4k**                lactose                       pyrano\[2,3-*d*\]pyrimidine    4.978 ± 0.018
  β-amino ester                                                                      
  **6a**                glucose                       chromene-3-carbonitrile        0.177 ± 0.020
  aminocarbonitrile                                                                  
  **6b**                lactose                       chromene-3-carbonitrile        0.169 ± 0.019
  aminocarbonitrile                                                                  
  **8a**                [d]{.smallcaps}-glucosamine   pyrido\[2,3-*d*\]pyrimidine    1.177 ± 0.013
  --Ph--CN              aminocarbonitrile                                            
  **8b**                [d]{.smallcaps}-glucosamine   pyrido\[2,3-*d*\]pyrimidine    1.643 ± 0.026
  --Ph--Br              aminocarbonitrile                                            
  **8c**                [d]{.smallcaps}-glucosamine   pyrido\[2,3-*d*\]pyrimidine    2.385 ± 0.018
  Ph--OMe               aminocarbonitrile                                            
  **8d**                [d]{.smallcaps}-glucosamine   pyrido\[2,3-*d*\]pyrimidine    3.242 ± 0.031
  Ph--NO~2~             aminocarbonitrile                                            

The experiments were performed in triplicate, and mean ± standard deviations (SDs) were determined.

As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, the significant antioxidant properties were observed for the synthetic compounds **4j**, **4k**, and **4c**. The antioxidant activity of these compounds changed with change of substructures. When in a class of compounds a part is fixed, it is observable that the antioxidant activity is changed remarkably, which can be attributed to the reducing (electron-donating) power of that fragment. For compounds **4a**--**e** (the heterocycle parts are pyrano\[2,3-*d*\]pyrimidine and aminocarbonitrile), results demonstrated that compound **4c** with arabinose carbohydrate is a superior antioxidant.^[@ref44]^ As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, the antioxidant activity of compounds containing galactose is less than that of others (**4b** and **4i**). With pyrano\[2,3-*d*\]pyrimidine compounds containing β-keto ester, the antioxidant activity is to some extent more than that of pyrano\[2,3-*d*\]pyrimidines incorporating aminocarbonitrile fragment, representing that the role of β-keto ester moiety is effective than that of aminocarbonitrile in antioxidant activity of these compounds.^[@ref45]^ The high antioxidant activity was obtained for the compounds containing aminocarbonitrile and β-amino ester moieties (**4j** and **4k**).^[@ref46]^ Also, the lowest antioxidant activity was observed for compound **6b** with a TEAC value of 0.169 ± 0.019 μM, which contains a chromene-3-carbonitrile moiety.^[@ref47]^ For compounds **8a**--**d**, which are pyrido\[2,3-*d*\]pyrimidine derivatives containing [d]{.smallcaps}-glucosamine, the antioxidant activity depends on the type of aryl ring, and for rings bearing nitro group (**8d**), a relatively good activity was obtained.^[@ref35]^

Also, data in [Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}, are in complete agreement with TEACs values ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The results presented in these figures suggest that the higher antioxidant activity associates with more reduction in the absorbance value at 734 nm. Antioxidant capacity of the synthetic ligands was measured using the 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) decolorization assay. To express antioxidant capacity, we used the water soluble vitamin E analogue as a standard compound. The reduction of the radical cation by the synthetic compounds was measured as the percentage inhibition of absorbance at 734 nm. The percentage inhibition curves were drawn as a function of concentration of the test compounds. The slope of these curves was obtained and divided with that of Trolox (4.87), and the final results were expressed as TEAC.^[@ref48]^

![Effects of time on suppression of the absorbance of the ABTS^•+^. The experiments were performed in different concentrations of each ligand (1.5--12 μM). The curves represent the effects of the specific antioxidant on the suppression of the absorbance of the ABTS^•+^ at 734 nm. The symbols used are as follows: control ABTS^•+^ radical cation (solid circles), **8a** (squares), **8b** (upward triangles), **8c** (downward triangles), and **8d** (diamonds).](ao-2018-01124q_0007){#fig1}

![Effects of time on suppression of the absorbance of the ABTS^•+^. The experiments were performed in different concentrations of each ligand (1.5--12 μM). The curves represent the effects of the specific antioxidant on the suppression of the absorbance of the ABTS^•+^ at 734 nm. The symbols used are as follows: control ABTS^•+^ radical cation (solid circles), **4f** (squares), **4g** (upward triangles), **4h** (downward triangles), and **4i** (diamonds).](ao-2018-01124q_0003){#fig2}

![Effects of time on suppression of the absorbance of the ABTS^•+^. The experiments were performed in different concentrations of each ligand (1.5--12 μM). The curves represent the effects of the specific antioxidant on the suppression of the absorbance of the ABTS^•+^ at 734 nm. The symbols used are as follows: control ABTS^•+^ radical cation (solid circles), **4a** (squares), **4b** (upward triangles), **4c** (downward triangles), **4d** (diamonds), **4e** (hollow circles), **4j** (hollow squares), **4k** (hollow upward triangles), **6a** (hollow downward triangles), and **6b** (hollow diamonds).](ao-2018-01124q_0010){#fig3}

Conclusions {#sec3}
===========

In summary, we have illustrated an efficient multicomponent approach for the synthesis of a new library of polyhydroxy-functionalized heterocyclic compounds using carbohydrates. In this protocol, reducing sugars act as aldehyde component and amino sugars act as amine component to participate in MCRs containing dicarbonyl compounds and malononitrile. These MCRs afforded a range of novel pyrano\[2,3-*d*\]pyrimidine, pyrido\[2,3-*d*\]pyrimidine, and chromene derivatives incorporating carbohydrate moieties and 3-aminocarbonitrile unite under environmental conditions. The method is simple, and gave the target products in good to excellent isolated yields and with high purity. The diversity of molecules in this study achieved by selection of carbohydrate (monosaccharide and disaccharide), dicarbonyl compound, and malononitrile, suggests an interesting scaffold containing both chiral polyhydroxy chain and biologically active heterocycles. The synthetic compounds revealed excellent antioxidant effectiveness in the ABTS system, which increases their potential therapeutic values.

Experimental Section {#sec4}
====================

General {#sec4.1}
-------

Chemicals were purchased from Fluka and Aldrich chemical companies and used without further purification. The known products were characterized by comparison of their spectra and physical data with those reported in the literature. Fourier transform infrared (FT-IR) spectroscopy (Shimadzu FT-IR 8300 spectrophotometer) was employed for characterization of the synthesized compounds. ^1^H NMR spectra were recorded at 250 and 400 MHz, and ^13^C NMR spectra were recorded at 62.5, 75, and 100 MHz in dimethyl sulfoxide-*d*~6~ using tetramethylsilane as an internal standard. Melting points were determined in open capillary tubes in a Barnstead Electrothermal 9100 BZ circulating oil melting point apparatus. Thin-layer chromatography (TLC) was carried out on silica gel 254 analytical sheets obtained from Fluka. Column chromatography was carried out on silica gel 60 Merck (230--240 mesh) in glass columns (2 or 3 cm diameter) using 15--30 g of silica gel per 1 g of the crude mixture.

Chemistry {#sec4.2}
---------

### General Procedure for Preparation of **4a--k** {#sec4.2.1}

A mixture of barbituric acid (1.0 mmol), sugar (1.0 mmol), malononitrile/diethyl malonate/ethylacetoacetate (1.0 mmol), and *para*-toluenesulfonic acid (30.0 mol %) in EtOH (5.0 mL) at 50 °C was stirred for 20 h. Completion of the reaction was confirmed by TLC (eluent EtOAc--MeOH). The reaction mixture was cooled to room temperature. Then, the reaction mixture was filtered and the remaining mixture was washed with ethanol (3 × 5 mL). Removal of the solvent under reduced pressure gave almost pure products, which were further purified by recrystallization from EtOH.

### Procedure To Prepare Compound **6a** and **6b** {#sec4.2.2}

A mixture of cyclohexane-1,3-dione (1 mmol), sugar (1 mmol), malononitrile (1 mmol), and PTSA (30 mol %) in EtOH (3 mL) at 50 °C was stirred for 15 h. Completion of the reaction was confirmed by TLC (eluent EtOAc--MeOH). The reaction mixture was cooled to room temperature. The extraction and purification of products were same as compound **4a**--**k**.

### General Procedure To Prepare Compound **8a**--**d** {#sec4.2.3}

A mixture of barbituric acid (1 mmol), aldehyde (1 mmol), [d]{.smallcaps}-glucosamine (1 mmol), and PTSA (10 mol %) in ethanol (5 mL) at 50 °C was stirred for 12 h. Completion of the reaction was confirmed by TLC (eluent CH~2~Cl~2~/MeOH). The reaction mixture was cooled to room temperature. The extraction and purification of products were same as those for compound **4a**--**k**.

Biology {#sec4.3}
-------

The ABTS procedure assay followed the method originally suggested by Re et al.^[@ref49]^ The ABTS radical cation (ABTS^•+^) was generated by reaction of ABTS solution (7 mM) and (2.45 mM final concentration) potassium persulfate solution at a molar ratio of 1:0.5. The mixture was held in dark at 25 °C for 12--16 h before being used, and then it was diluted with 5 mM phosphate buffer (pH 7.4) to obtain an absorbance of 0.7 ± 0.02 units at 734 nm using a T90^+^ UV--vis spectrophotometer. An accurate amount of sample was added to 1 mL of the reagent and incubated at 25 °C. Then, the decrease of absorbance at 734 nm was measured at the end point of 6 min. A solvent blank was run in each assay and a water soluble vitamin E analogue (Trolox) used as the standard. The results were expressed as Trolox equivalent antioxidant capacity (TEAC).

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.8b01124](http://pubs.acs.org/doi/abs/10.1021/acsomega.8b01124).Spectral data for synthesized compounds and copy of ^1^H NMR, ^13^C NMR, and FT-IR of products ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b01124/suppl_file/ao8b01124_si_001.pdf))
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